Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 13 |
NetGPI | no | yes: 0, no: 13 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005930 | axoneme | 2 | 2 |
GO:0097542 | ciliary tip | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0005737 | cytoplasm | 2 | 1 |
Related structures:
AlphaFold database: A0A3Q8IQ71
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 4 | 6 | PF00675 | 0.584 |
CLV_PCSK_KEX2_1 | 162 | 164 | PF00082 | 0.526 |
CLV_PCSK_KEX2_1 | 4 | 6 | PF00082 | 0.601 |
CLV_PCSK_PC1ET2_1 | 162 | 164 | PF00082 | 0.526 |
CLV_PCSK_PC1ET2_1 | 4 | 6 | PF00082 | 0.610 |
DEG_SPOP_SBC_1 | 68 | 72 | PF00917 | 0.698 |
DEG_SPOP_SBC_1 | 88 | 92 | PF00917 | 0.351 |
DOC_MAPK_FxFP_2 | 17 | 20 | PF00069 | 0.486 |
DOC_PP2B_LxvP_1 | 110 | 113 | PF13499 | 0.287 |
DOC_PP4_FxxP_1 | 17 | 20 | PF00568 | 0.486 |
DOC_USP7_MATH_1 | 136 | 140 | PF00917 | 0.252 |
DOC_USP7_MATH_1 | 20 | 24 | PF00917 | 0.471 |
DOC_USP7_MATH_1 | 45 | 49 | PF00917 | 0.672 |
DOC_USP7_MATH_1 | 69 | 73 | PF00917 | 0.712 |
DOC_USP7_MATH_1 | 88 | 92 | PF00917 | 0.674 |
DOC_USP7_UBL2_3 | 28 | 32 | PF12436 | 0.659 |
LIG_APCC_ABBA_1 | 153 | 158 | PF00400 | 0.384 |
LIG_FHA_1 | 44 | 50 | PF00498 | 0.698 |
LIG_LIR_Apic_2 | 14 | 20 | PF02991 | 0.487 |
LIG_PDZ_Class_2 | 177 | 182 | PF00595 | 0.489 |
LIG_Pex14_1 | 164 | 168 | PF04695 | 0.525 |
LIG_SH2_CRK | 84 | 88 | PF00017 | 0.652 |
LIG_SH2_STAT5 | 118 | 121 | PF00017 | 0.267 |
LIG_SH2_STAT5 | 156 | 159 | PF00017 | 0.268 |
LIG_SUMO_SIM_par_1 | 108 | 114 | PF11976 | 0.465 |
MOD_CK1_1 | 111 | 117 | PF00069 | 0.314 |
MOD_CK1_1 | 41 | 47 | PF00069 | 0.693 |
MOD_CK1_1 | 48 | 54 | PF00069 | 0.708 |
MOD_CK2_1 | 136 | 142 | PF00069 | 0.249 |
MOD_CK2_1 | 20 | 26 | PF00069 | 0.517 |
MOD_Cter_Amidation | 160 | 163 | PF01082 | 0.330 |
MOD_GlcNHglycan | 113 | 116 | PF01048 | 0.279 |
MOD_GlcNHglycan | 40 | 43 | PF01048 | 0.604 |
MOD_GlcNHglycan | 71 | 74 | PF01048 | 0.680 |
MOD_GlcNHglycan | 91 | 94 | PF01048 | 0.419 |
MOD_GSK3_1 | 41 | 48 | PF00069 | 0.652 |
MOD_GSK3_1 | 64 | 71 | PF00069 | 0.746 |
MOD_NEK2_1 | 127 | 132 | PF00069 | 0.253 |
MOD_NEK2_1 | 13 | 18 | PF00069 | 0.695 |
MOD_NEK2_1 | 87 | 92 | PF00069 | 0.623 |
MOD_NEK2_2 | 20 | 25 | PF00069 | 0.470 |
MOD_PKA_2 | 116 | 122 | PF00069 | 0.420 |
MOD_Plk_4 | 136 | 142 | PF00069 | 0.303 |
MOD_Plk_4 | 20 | 26 | PF00069 | 0.531 |
MOD_SUMO_for_1 | 178 | 181 | PF00179 | 0.528 |
TRG_ENDOCYTIC_2 | 84 | 87 | PF00928 | 0.614 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IB90 | Leptomonas seymouri | 63% | 100% |
A0A0S4KPG9 | Bodo saltans | 31% | 92% |
A0A1X0NSQ0 | Trypanosomatidae | 40% | 100% |
A0A3S5H6F3 | Leishmania donovani | 33% | 82% |
A0A422NAN4 | Trypanosoma rangeli | 39% | 100% |
A4HUC7 | Leishmania infantum | 35% | 100% |
A4I327 | Leishmania infantum | 99% | 100% |
C9ZJK1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 37% | 100% |
E9ACU8 | Leishmania major | 96% | 100% |
E9AI39 | Leishmania braziliensis | 34% | 100% |
E9AZD7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
Q4QHJ9 | Leishmania major | 36% | 82% |
Q6VTH5 | Cyprinus carpio | 32% | 83% |
V5BCY8 | Trypanosoma cruzi | 37% | 100% |
V5BX28 | Trypanosoma cruzi | 27% | 71% |